Recruiting
Phase 1
Phase 2

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Sponsor:

Eureka Therapeutics Inc.

Code:

NCT04634357

Conditions

Hepatoblastoma

Hepatocellular Carcinoma (HCC)

Liver Neoplasms

Metastatic Liver Cancer

Liver Cancer

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

ET140203 T Cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information